| Ödenmemiş Hisseler | 11,617,250 shares |
| İçeriden Öğrenenlerin Hisseleri | 102.563.537 shares |
| Toplam İçeriden Öğrenenler | 19 |
İçeriden Öğrenenlerin Eğilim Skoru
İçeriden Öğrenenlerin Eğilim Skoru, kurumsal içeriden öğrenenler tarafından satın alınan şirketleri bulur.
En yüksek düzeyde içeriden öğrenen birikimine sahip şirketleri tanımlayan karmaşık, çok faktörlü kantitatif bir modelin sonucudur. Skorlama modeli, önceki 90 günde satın alan içeriden öğrenenlerin net sayısının, float yüzde olarak satın alınan toplam hisselerin ve içeriden öğrenenlerin sahip olduğu toplam hisselerin bir kombinasyonunu kullanıyor. Sayı 0 ila 100 arasında değişir; daha yüksek sayılar, emsallerine göre daha yüksek bir birikim düzeyine işaret eder ve 50 ortalamadır.
Güncelleme Sıklığı: Günlük
Şirket Yetkilisi Eğilim Skoru
Şirket Yetkilisi Eğilim Skoru, Kurumsal Şirket Yetkilileri tarafından satın alınan şirketleri bulur.
Tanım gereği Kurumsal Yetkililer, Kurumsal İçeriden Öğrenenlerdir, ancak diğer İçeriden Öğrenenlerin (% 10 Hissedarlar ve Yönetim Kurulu Üyeleri) aksine, Şirket Yetkilileri günlük olarak şirket için çalışırlar ve alım satım yaparken kendi paralarını kullanırlar . (%10 Hissedarlar ve Yönetim Kurulu Üyeleri genellikle başkalarının parasını yöneten fon yöneticileridir.) Bu sebeple, Şirket Yetkilileri tarafından yapılan içeriden öğrenenlerin ticareti çok daha önemlidir ve uygun şekilde ele alınmalıdır.
İçeriden Öğrenenlerin Eğilim Skoru gibi, Şirket Yetkilileri Eğilim Skoru en yüksek düzeyde şirket yetkilisi birikimine sahip şirketleri belirleyen gelişmiş, çok faktörlü kantitatif bir modelin sonucudur.
Güncelleme Sıklığı: Günlük
Anahtar İçeriden Öğrenen Metrikleri
Bu kart, şirketin çeşitli içeriden öğrenilen ölçümlere kıyasla nasıl sıralandığını gösterir. Yüzdelik sıralama, bu şirketin ABD pazarındaki diğer şirketlerle nasıl karşılaştırıldığını gösterir. Daha yüksek sıralamalar daha iyi durumların göstergesidir.
Örneğin, içeriden öğrenen alımlarının olumlu bir gösterge olduğu genel olarak kabul edilir, bu sebeple içeriden öğrenenlerin alımının daha yüksek olduğu şirketler, içeriden satın alan (hatta içeriden öğrenenlerin satışı) daha az olan şirketlere göre daha üst sıralarda yer alır.
Alım Yapan İçeriden Öğrenen Net Sayısı (Sıra)
9120 out of 10931
Alım Yapan İçeriden Öğrenen Net Sayısı, alım yapan içeriden öğrenenlerin toplam sayısından son 90 gün içinde satış yapan içeriden öğrenenlerin toplam sayısı çıkarılarak elde edilir. Yüzdelik sıralama burada gösterilir (%0 ile %100 arası).
İçeriden Öğrenenler Tarafından Satın Alınan Float Yüzdesi (Sıra)
9031 out of 10786
İçerden Öğrenenler Tarafından Satın Alınan Float Yüzdesi, içeriden öğrenenler tarafından satın alınan toplam hisse sayısından, son 90 gün içinde içeriden öğrenenler tarafından satılan toplam hisse sayısı çıkarılarak elde edilen toplam floata bölünür ve 100 ile çarpılır.
İçeriden Öğrenenlerin Ticareti Tablosu
Phio Pharmaceuticals Corp. içeriden öğrenenlerin ticareti aşağıdaki grafikte gösterilmektedir. İçeriden öğrenenler bir şirketteki yetkililer, yöneticiler veya önemli yatırımcılardır. Genel olarak, içeriden öğrenenlerin maddi, kamuya açıklanmamış bilgilere dayanarak şirketlerinde alım satım yapması genellikle yasa dışıdır. Bu onların kendi şirketlerinde herhangi bir işlem yapmalarının yasa dışı olduğu anlamına gelmez. Ancak tüm işlemleri Form 4 aracılığıyla SECye bildirilmesi gerekir.
İçeriden Öğrenenlerin Listesi ve Kârlılık Metrikleri
Bu tablo bilindik içeriden öğrenenlerin listesini gösterir ve SECye bildirilen dosyalardan otomatik olarak oluşturulur. İsimlere ek olarak, en son unvana ve yönetici, yetkili veya %10luk sahiplik tanımına ek olarak, açıklanan en son varlıkları da sağlıyoruz. Ek olarak, mümkün olduğunda içeriden öğrenen için geçmiş ticari performansı da sağlıyoruz. Geçmiş ticari performans, içeriden öğrenenlerin yaptığı gerçek açık piyasa satın alma işlemlerinin performansının ağırlıklı ortalamasıdır. Bunun nasıl hesaplandığı hakkında daha fazla bilgi için bu YouTube web seminerini izleyiniz.
See our leaderboard of most profitable insider traders.
| İçeriden Öğrenen | Ort Kâr (%) | Sahibi Olan Hisseler |
Bölünmüş Düzeltilmiş |
|---|---|---|---|
| Advanced RNA Technologies, LLC - | 1.221.723 | 1.221.723 | |
| Patricia A Bradford Director - [D] | 45.651 | 45.651 | |
| John A Barrett Chief Development Officer - [O] | 222.991 | 8.802 | |
| Robert J Bitterman Chairman, Pres. & CEO, Director - [D] [O] | 411.421 | 411.421 | |
| Keith L Brownlie Director - [D] | 20.000 | 789 | |
| Geert Cauwenbergh Director - [D] | 4.235 | 471 |
| İçeriden Öğrenen | Ort Kâr (%) | Sahibi Olan Hisseler |
Bölünmüş Düzeltilmiş |
|---|---|---|---|
| Lisa Cabott Carson Chief Financial Officer - [O] | 94.000 | 94.000 | |
| David H Deming Director - [D] | 37.800 | 37.800 | |
| Gerrit Dispersyn President & CEO, Director - [D] [O] | 212.327 | 20.222 | |
| Dorman H. Paul Director - [D] | 20.370 | 1.940 | |
| Alexey Eliseev Chief Business Officer - [O] | 950.312 | 950.312 | |
| Robert L Ferrara Director - [D] | 38.766 | 38.766 |
| İçeriden Öğrenen | Ort Kâr (%) | Sahibi Olan Hisseler |
Bölünmüş Düzeltilmiş |
|---|---|---|---|
| Jonathan E Freeman Director - [D] | 32.655 | 32.655 | |
|
Galena Biopharma, Inc.
10% Owner -
|
32.393.095 | 32.393.095 | |
| Infarinato Robert M. VP, CFO - [O] | 11.000 | 11.000 | |
| Caitlin Kontulis Secretary & VP Finance & Admin - [O] | 10.643 | 1.183 | |
| Curtis Lockshin Director - [D] | 35.155 | 35.155 | |
|
Opko Health, Inc.
10% Owner -
|
67.241.380 | 67.241.380 | |
| Pamela Pavco Chief Development Officer - [O] | 17.173 | 17.173 |
Report errors via our new Insider Auditing Tool
İçeriden Öğrenenlerin Alımlarının Takip Kayıtları - Kısa Vadeli Kâr Analizi
Bu bölümde, PHIO / Phio Pharmaceuticals Corp. yılında yapılmış her planlanmamış, açık piyasada içeriden öğrenlenlerin satın almalarının kârlılığını analiz ediyoruz. Bu analiz, içeriden öğrenen kişinin sürekli olarak anormal getiriler sağlayıp sağlamadığını ve takip edilmeye değer olup olmadığını anlamaya yardımcı olur. Bu analiz her işlemin ardından bir yıl süreyle geçerlidir ve sonuçlar teoriktir .
Aşağıdaki tablo, otomatik ticaret planının parçası olmayan en son açık piyasa alımlarını göstermektedir.
Düzeltilmiş Fiyat bölünmüş olarak düzeltilmiş fiyattır. Düzeltilmiş Hisseler bölünmüş olarak düzeltilmiş hisselerdir.
İçeriden Öğrenen Satışlarının Takip Kayıtları - Kısa Vadeli Zarar Analizi
Bu bölümde, PHIO / Phio Pharmaceuticals Corp. yılında yapılan her planlanmamış, açık piyasa içeriden öğrenilen satışın kısa vadeli zarardan kaçınma miktarını analiz ediyoruz. Tutarlı bir kayıptan kaçınma modeli, gelecekteki satış işlemlerinin fiyattaki düşüşleri öngörebileceğini düşündürebilir. Bu analiz her işlemin ardından bir yıl süreyle geçerlidir ve sonuçlar teoriktir .
Aşağıdaki tablo, otomatik ticaret planının parçası olmayan en son açık piyasa satışlarını göstermektedir.
Düzeltilmiş Fiyat bölünmüş olarak düzeltilmiş fiyattır. Düzeltilmiş Hisseler bölünmüş olarak düzeltilmiş hisselerdir.
İşlem Geçmişi
Tam işlem geçmişini görmek için bağlantı simgesine tıklayın. 10b5-1 otomatik işlem planı kapsamında bildirilen işlemlerin 10b-5 ile işaretli sütununda X işareti bulunacaktır.
| Dosya Tarih |
Ticaret Tarihi |
Form | İçeriden Öğrenenler | Ticker | Menkul Kıymet Başlığı | Kod | Doğrudan | İşleme Koyma Fiyatı |
Birim Fiyatı |
Birimler Değiştirildi |
Değer Değiştirildi (1K) |
Geriye Kalan Opsiyonlar |
Geriye Kalan Hisseler |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-06 | 2026-02-05 | 4 | Freeman Jonathan E | PHIO | Common Stock, $.0001 par value | D | 16.600 | 32.655 | ||||||
| 2026-02-06 | 2026-02-05 | 4 | Lockshin Curtis | PHIO | Common Stock, $.0001 par value | D | 16.600 | 35.155 | ||||||
| 2026-02-06 | 2026-02-05 | 4 | Carson Lisa Cabott | PHIO | Common Stock, $.0001 par value | D | 47.000 | 94.000 | ||||||
| 2026-02-06 | 2026-02-05 | 4 | Deming David H | PHIO | Common Stock, $.0001 par value | D | 23.800 | 37.800 | ||||||
| 2026-02-06 | 2026-02-05 | 4 | BRADFORD PATRICIA A | PHIO | Common Stock, $.0001 par value | D | 18.500 | 45.651 | ||||||
| 2026-02-06 | 2026-02-05 | 4 | Bitterman Robert J | PHIO | Common Stock, $.0001 par value | D | 120.000 | 411.421 | ||||||
| 2026-01-02 | 2025-12-31 | 4 | Bitterman Robert J | PHIO | Common Stock, $.0001 par value | D | 1,0300 | 5.000 | 5 | 291.421 | ||||
| 2025-12-29 | 2025-12-23 | 4 | Bitterman Robert J | PHIO | Common Stock, $.0001 par value | D | 1,0200 | 5.000 | 5 | 286.421 | ||||
| 2025-11-24 | 2025-11-21 | 4 | Bitterman Robert J | PHIO | Common Stock, $.0001 par value | D | 1,1400 | 5.000 | 6 | 281.421 | ||||
| 2025-11-19 | 2025-11-18 | 4 | Bitterman Robert J | PHIO | Common Stock, $.0001 par value | D | 1,2700 | 5.000 | 6 | 276.421 | ||||
| 2025-09-15 | 2025-09-11 | 4/A | Ferrara Robert L | PHIO | Common Stock, $.0001 par value | D | 23.100 | 38.766 | ||||||
| 2025-09-15 | 2025-09-11 | 4 | Deming David H | PHIO | Common Stock, $.0001 par value | D | 14.000 | 14.000 | ||||||
| 2025-09-15 | 2025-09-11 | 4 | Ferrara Robert L | PHIO | Common Stock, $.0001 par value | D | 23.000 | 38.666 | ||||||
| 2025-09-15 | 2025-09-11 | 4 | Freeman Jonathan E | PHIO | Common Stock, $.0001 par value | D | 14.700 | 16.055 | ||||||
| 2025-09-15 | 2025-09-11 | 4 | Lockshin Curtis | PHIO | Common Stock, $.0001 par value | D | 16.200 | 18.555 | ||||||
| 2025-09-15 | 2025-09-11 | 4 | BRADFORD PATRICIA A | PHIO | Common Stock, $.0001 par value | D | 18.800 | 27.151 | ||||||
| 2025-09-15 | 2025-09-11 | 4 | Carson Lisa Cabott | PHIO | Common Stock, $.0001 par value | D | 47.000 | 47.000 | ||||||
| 2025-09-15 | 2025-09-11 | 4 | Bitterman Robert J | PHIO | Common Stock, $.0001 par value | D | 250.000 | 271.421 | ||||||
| 2025-09-15 | 2025-09-11 | 4 | Bitterman Robert J | PHIO | Common Stock, $.0001 par value | D | 2,3200 | -4.111 | -10 | 21.421 | ||||
| 2025-06-11 | 2025-06-10 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 2,4199 | 2.500 | 6 | 15.666 | ||||
| 2025-06-11 | 2025-06-10 | 4 | Bitterman Robert J | PHIO | Common Stock, $0.0001 par value | D | 2,4200 | 2.000 | 5 | 27.149 | ||||
| 2025-06-10 | 2025-06-09 | 4 | Bitterman Robert J | PHIO | Common Stock, $0.0001 par value | D | 2,7500 | 1.500 | 4 | 25.149 | ||||
| 2025-05-23 | 2025-05-22 | 4 | Bitterman Robert J | PHIO | Common Stock, $0.0001 par value | D | 1,7799 | 1.200 | 2 | 23.649 | ||||
| 2025-05-23 | 2025-05-21 | 4 | Bitterman Robert J | PHIO | Common Stock, $0.0001 par value | D | 1,7700 | 3.000 | 5 | 22.449 | ||||
| 2025-05-21 | 2025-05-20 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 1,8200 | 2.500 | 5 | 13.166 | ||||
| 2024-09-13 | 2024-09-11 | 4 | Bitterman Robert J | PHIO | Common Stock, $0.0001 par value | D | 15.500 | 17.832 | ||||||
| 2024-09-13 | 2024-09-11 | 4 | Freeman Jonathan E | PHIO | Common Stock, $0.0001 par value | D | 1.000 | 1.000 | ||||||
| 2024-09-13 | 2024-09-11 | 4 | Infarinato Robert M. | PHIO | Common Stock, $0.0001 Par Value | D | 3.000 | 11.000 | ||||||
| 2024-09-12 | 2024-09-11 | 4 | Lockshin Curtis | PHIO | Common Stock, $0.0001 par value | D | 2.000 | 2.000 | ||||||
| 2024-09-12 | 2024-09-11 | 4 | BRADFORD PATRICIA A | PHIO | Common Stock, $0.0001 par value | D | 8.000 | 8.000 | ||||||
| 2024-09-12 | 2024-09-11 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 10.000 | 10.000 | ||||||
| 2024-08-15 | 2024-08-13 | 4 | Infarinato Robert M. | PHIO | Common stock, $0.0001 par value | D | 8.000 | 8.000 | ||||||
| 2024-06-11 | 2024-06-07 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,7400 | 1.000 | 1 | 20.990 | ||||
| 2024-06-10 | 2024-06-06 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,7500 | 1.000 | 1 | 19.990 | ||||
| 2024-03-05 | 2024-03-01 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 0,9580 | -335 | -0 | 10.643 | ||||
| 2024-02-27 | 2024-02-26 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,9100 | 2.500 | 2 | 18.990 | ||||
| 2024-02-22 | 2024-02-20 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,7600 | -1.804 | -1 | 16.490 | ||||
| 2024-02-20 | 2024-02-17 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 0,6600 | -523 | -0 | 10.978 | ||||
| 2024-02-20 | 2024-02-15 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 0,6500 | -658 | -0 | 11.501 | ||||
| 2023-10-03 | 2023-10-01 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 1,5100 | -917 | -1 | 18.294 | ||||
| 2023-07-05 | 2023-07-01 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 2,8400 | 1.000 | 3 | 19.211 | ||||
| 2023-07-05 | 2023-06-30 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 2,8800 | 1.000 | 3 | 18.211 | ||||
| 2023-06-15 | 2023-06-14 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 3,1000 | 2.000 | 6 | 6.000 | ||||
| 2023-03-03 | 2023-03-01 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 5,4900 | -335 | -2 | 12.159 | ||||
| 2023-02-22 | 2023-02-17 | 4 | Lockshin Curtis | PHIO | Common stock, $0.0001 par value | D | 1.500 | 3.197 | ||||||
| 2023-02-22 | 2023-02-17 | 4 | BRADFORD PATRICIA A | PHIO | Common stock, $0.0001 par value | D | 1.500 | 3.167 | ||||||
| 2023-02-22 | 2023-02-20 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 11.000 | 17.211 | ||||||
| 2023-02-22 | 2023-02-17 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 1.500 | 4.000 | ||||||
| 2023-02-22 | 2023-02-17 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 1.500 | 4.235 | ||||||
| 2023-02-22 | 2023-02-17 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 4.500 | 12.494 | ||||||
| 2023-02-22 | 2023-02-17 | 4 | Freeman Jonathan E | PHIO | Common stock, $0.0001 par value | D | 1.500 | 3.197 | ||||||
| 2023-02-17 | 2023-02-15 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 5,2000 | -657 | -3 | 7.994 | ||||
| 2022-12-15 | 2022-12-14 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,3900 | 2.000 | 1 | 74.541 | ||||
| 2022-12-08 | 2022-12-07 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,3900 | 2.000 | 1 | 72.541 | ||||
| 2022-12-06 | 2022-12-05 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,4300 | 2.000 | 1 | 70.541 | ||||
| 2022-12-05 | 2022-12-02 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 0,4082 | 5.000 | 2 | 30.000 | ||||
| 2022-11-29 | 2022-11-29 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,4000 | 215 | 0 | 68.541 | ||||
| 2022-11-29 | 2022-11-25 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,4200 | 2.500 | 1 | 68.326 | ||||
| 2022-11-28 | 2022-11-23 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 0,4099 | 2.000 | 1 | 25.000 | ||||
| 2022-11-16 | 2022-11-16 | 4 | Bitterman Robert J | PHIO | Series D Preferred Stock, $0.0001 par value | D | 1.750,0000 | 1 | 2 | 1 | ||||
| 2022-10-03 | 2022-10-01 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 40.000 | 65.826 | ||||||
| 2022-09-26 | 2022-08-09 | 4 | BRADFORD PATRICIA A | PHIO | Common stock, $0.0001 par value | D | 20.000 | 20.000 | ||||||
| 2022-03-03 | 2022-03-01 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 0,8210 | -4.011 | -3 | 103.815 | ||||
| 2022-03-03 | 2022-03-01 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 0,8210 | -8.954 | -7 | 212.327 | ||||
| 2022-02-16 | 2022-02-15 | 4 | Lockshin Curtis | PHIO | Common stock, $0.0001 par value | D | 10.000 | 20.366 | ||||||
| 2022-02-16 | 2022-02-15 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 68.000 | 107.826 | ||||||
| 2022-02-16 | 2022-02-15 | 4 | Freeman Jonathan E | PHIO | Common stock, $0.0001 par value | D | 10.000 | 20.364 | ||||||
| 2022-02-16 | 2022-02-15 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 10.000 | 23.000 | ||||||
| 2022-02-16 | 2022-02-15 | 4 | Dorman H. Paul | PHIO | Common stock, $0.0001 par value | D | 10.000 | 20.370 | ||||||
| 2022-02-16 | 2022-02-15 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 126.000 | 221.281 | ||||||
| 2022-02-16 | 2022-02-15 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 10.000 | 32.822 | ||||||
| 2022-02-16 | 2022-02-15 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 10.000 | 25.826 | ||||||
| 2021-08-17 | 2021-08-16 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 1,6300 | 6.000 | 10 | 95.281 | ||||
| 2021-03-05 | 2021-03-04 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 2,5600 | 1.953 | 5 | 89.281 | ||||
| 2021-03-03 | 2021-03-01 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 10.000 | 15.826 | ||||||
| 2021-03-03 | 2021-03-01 | 4 | Freeman Jonathan E | PHIO | Common stock, $0.0001 par value | D | 10.000 | 10.364 | ||||||
| 2021-03-03 | 2021-03-03 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 3,1500 | 682 | 2 | 13.000 | ||||
| 2021-03-03 | 2021-03-01 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 10.000 | 12.318 | ||||||
| 2021-03-03 | 2021-03-01 | 4 | Lockshin Curtis | PHIO | Common stock, $0.0001 par value | D | 10.000 | 10.366 | ||||||
| 2021-03-03 | 2021-03-01 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 10.000 | 22.822 | ||||||
| 2021-03-03 | 2021-03-01 | 4 | Dorman H. Paul | PHIO | Common stock, $0.0001 par value | D | 10.000 | 10.370 | ||||||
| 2021-03-03 | 2021-03-03 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 3,0300 | 2.500 | 8 | 87.328 | ||||
| 2021-03-03 | 2021-03-01 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 68.450 | 84.828 | ||||||
| 2021-03-03 | 2021-03-01 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 34.600 | 39.826 | ||||||
| 2020-08-19 | 2020-08-19 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 2,5000 | 2.000 | 5 | 16.377 | ||||
| 2020-03-03 | 2020-03-01 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 2,9300 | -673 | -2 | 14.628 | ||||
| 2019-11-20 | 2019-11-18 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 0,1000 | 237.500 | 24 | 279.030 | ||||
| 2019-11-20 | 2019-11-18 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 0,1000 | 350.000 | 35 | 827.817 | ||||
| 2019-11-20 | 2019-11-18 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,1000 | 300.000 | 30 | 320.440 | ||||
| 2019-11-20 | 2019-11-18 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 0,1000 | 127.500 | 13 | 127.500 | ||||
| 2019-11-20 | 2019-11-18 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,1000 | 225.000 | 22 | 704.841 | ||||
| 2019-08-02 | 2019-08-01 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 0,4030 | -749 | -0 | 41.530 | ||||
| 2019-08-02 | 2019-08-01 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 0,4030 | -1.236 | -0 | 477.817 | ||||
| 2019-08-02 | 2019-08-01 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,4030 | -1.751 | -1 | 479.841 | ||||
| 2019-04-24 | 2019-04-22 | 4 | Barrett John A | PHIO | Common stock, $0.0001 par value | D | 222.991 | 222.991 | ||||||
| 2019-03-05 | 2019-03-01 | 4 | Dispersyn Gerrit | PHIO | Common Stock | D | 407.703 | 479.053 | ||||||
| 2019-03-01 | 2019-02-28 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,3798 | 152.415 | 58 | 481.592 | ||||
| 2019-02-19 | 2019-02-15 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,3634 | 22.279 | 8 | 329.177 | ||||
| 2019-02-15 | 2019-02-13 | 4 | Dorman H. Paul | PHIO | Common stock | D | 10.000 | 20.375 | ||||||
| 2019-02-15 | 2019-02-13 | 4 | Lockshin Curtis | PHIO | Common stock | D | 10.000 | 20.130 | ||||||
| 2019-02-15 | 2019-02-13 | 4 | Freeman Jonathan E | PHIO | Common stock | D | 10.000 | 20.000 | ||||||
| 2019-02-15 | 2019-02-13 | 4 | Dispersyn Gerrit | PHIO | Common stock | D | 55.000 | 71.350 | ||||||
| 2019-02-15 | 2019-02-13 | 4 | Kontulis Caitlin | PHIO | Common stock | D | 27.000 | 40.214 | ||||||
| 2019-02-15 | 2019-02-13 | 4 | Bitterman Robert J | PHIO | Common stock | D | 10.000 | 20.440 | ||||||
| 2019-02-15 | 2019-02-13 | 4 | Brownlie Keith L | PHIO | Common stock | D | 10.000 | 20.000 | ||||||
| 2019-02-04 | 2019-02-01 | 4 | CAUWENBERGH GEERT | PHIO | Common Stock, $0.0001 par value | D | 0,3771 | 21.470 | 8 | 306.898 | ||||
| 2019-01-22 | 2019-01-18 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,3412 | 23.729 | 8 | 285.428 | ||||
| 2019-01-07 | 2019-01-04 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,3499 | 23.139 | 8 | 261.699 | ||||
| 2018-12-26 | 2018-12-21 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,2950 | 27.445 | 8 | 238.560 | ||||
| 2018-12-10 | 2018-12-07 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,3700 | 21.882 | 8 | 211.115 | ||||
| 2018-11-26 | 2018-11-23 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,3121 | 25.941 | 8 | 189.233 | ||||
| 2018-11-13 | 2018-11-09 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,4330 | 18.698 | 8 | 163.292 | ||||
| 2018-10-29 | 2018-10-26 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,4372 | 18.519 | 8 | 144.594 | ||||
| 2018-10-15 | 2018-10-12 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,4699 | 17.230 | 8 | 126.075 | ||||
| 2018-10-01 | 2018-09-28 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 1,1700 | 73.587 | 86 | 108.845 | ||||
| 2018-08-03 | 2018-08-01 | 4 | Dorman H. Paul | RXII | Common Stock | D | 10.000 | 10.375 | ||||||
| 2018-08-03 | 2018-08-01 | 4 | Freeman Jonathan E | RXII | Common Stock | D | 10.000 | 10.000 | ||||||
| 2018-08-03 | 2018-08-01 | 4 | Lockshin Curtis | RXII | Common Stock | D | 10.000 | 10.130 | ||||||
| 2018-08-03 | 2018-08-01 | 4 | Kontulis Caitlin | RXII | Stock option (right to buy) | D | 1,79 | 10.500 | 10.500 | |||||
| 2018-08-03 | 2018-08-01 | 4 | Kontulis Caitlin | RXII | Common Stock | D | 10.500 | 11.024 | ||||||
| 2018-08-03 | 2018-08-01 | 4 | Dispersyn Gerrit | RXII | Stock option (right to buy) | D | 1,79 | 16.000 | 16.000 | |||||
| 2018-08-03 | 2018-08-01 | 4 | Dispersyn Gerrit | RXII | Common Stock | D | 16.000 | 16.350 | ||||||
| 2018-08-03 | 2018-08-01 | 4 | CAUWENBERGH GEERT | RXII | Stock option (right to buy) | D | 1,79 | 21.000 | 21.000 | |||||
| 2018-08-03 | 2018-08-01 | 4 | CAUWENBERGH GEERT | RXII | Common Stock | D | 21.000 | 35.258 | ||||||
| 2018-08-03 | 2018-08-01 | 4 | Bitterman Robert J | RXII | Common Stock | D | 10.000 | 10.440 | ||||||
| 2018-08-03 | 2018-08-01 | 4 | Brownlie Keith L | RXII | Common Stock | D | 10.000 | 10.000 | ||||||
| 2017-10-02 | 2017-10-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,4500 | 7.100 | 3 | 142.583 | ||||
| 2017-10-02 | 2017-10-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,4600 | 200 | 0 | 135.483 | ||||
| 2017-10-02 | 2017-10-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,4400 | 2.700 | 1 | 135.283 | ||||
| 2017-09-07 | 2017-09-07 | 4 | Eliseev Alexey | RXII | Common stock, par value $0.0001 | D | 0,5283 | -58.712 | -31 | 950.312 | ||||
| 2017-09-07 | 2017-09-06 | 4 | Eliseev Alexey | RXII | Common stock, par value $0.0001 | D | 0,5365 | -91.907 | -49 | 1.009.024 | ||||
| 2017-09-07 | 2017-09-05 | 4 | Eliseev Alexey | RXII | Common stock, par value $0.0001 | D | 0,5571 | -26.181 | -15 | 1.100.931 | ||||
| 2017-09-01 | 2017-09-01 | 4 | Eliseev Alexey | RXII | Common stock, $0.0001 par value | D | 0,5682 | -23.200 | -13 | 1.127.112 | ||||
| 2017-08-24 | 2017-08-24 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,5600 | 739 | 0 | 132.583 | ||||
| 2017-08-24 | 2017-08-24 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,5500 | 4.361 | 2 | 131.844 | ||||
| 2017-08-24 | 2017-08-24 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,5450 | 4.900 | 3 | 127.483 | ||||
| 2017-06-26 | 2017-06-23 | 4 | Dispersyn Gerrit | RXII | Common stock, $0.0001 par value | D | 0,6200 | 3.500 | 2 | 3.500 | ||||
| 2017-06-22 | 2017-06-22 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6200 | 5.000 | 3 | 122.583 | ||||
| 2017-06-22 | 2017-06-22 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6300 | 5.000 | 3 | 117.583 | ||||
| 2017-06-09 | 2017-06-09 | 4 | Eliseev Alexey | RXII | Series C Convertible Preferred Stock, $0.0001 par value | D | -332.499 | 0 | ||||||
| 2017-06-09 | 2017-06-09 | 4 | Eliseev Alexey | RXII | Common stock, $0.0001 par value | D | 332.499 | 1.150.312 | ||||||
| 2017-06-07 | 2017-06-06 | 4 | Freeman Jonathan E | RXII | Stock option (right to buy) | D | 0,54 | 3.500 | 3.500 | |||||
| 2017-04-26 | 2017-04-24 | 4 | Dispersyn Gerrit | RXII | Stock option (right to buy) | D | 0,65 | 95.000 | 95.000 | |||||
| 2017-04-26 | 2017-04-26 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6480 | 10.000 | 6 | 112.583 | ||||
| 2017-03-20 | 2017-03-17 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,7655 | 15 | 0 | 102.583 | ||||
| 2017-03-20 | 2017-03-17 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,7651 | 665 | 1 | 102.568 | ||||
| 2017-03-20 | 2017-03-17 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,7695 | 9.320 | 7 | 101.903 | ||||
| 2017-02-21 | 2017-02-17 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6950 | 2.917 | 2 | 92.583 | ||||
| 2017-02-21 | 2017-02-17 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6924 | 6.883 | 5 | 89.666 | ||||
| 2017-02-21 | 2017-02-17 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6915 | 200 | 0 | 82.783 | ||||
| 2017-02-08 | 2017-02-08 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6850 | 10.000 | 7 | 82.583 | ||||
| 2017-02-03 | 2017-02-01 | 4 | CAUWENBERGH GEERT | RXII | Stock option (right to buy) | D | 0,63 | 13.000 | 13.000 | |||||
| 2017-02-03 | 2017-02-01 | 4 | Pavco Pamela | RXII | Stock option (right to buy) | D | 0,63 | 7.000 | 7.000 | |||||
| 2017-02-03 | 2017-02-01 | 4 | Bitterman Robert J | RXII | Stock option (right to buy) | D | 0,63 | 2.000 | 2.000 | |||||
| 2017-02-03 | 2017-02-01 | 4 | Brownlie Keith L | RXII | Stock option (right to buy) | D | 0,63 | 2.000 | 2.000 | |||||
| 2017-02-03 | 2017-02-01 | 4 | Lockshin Curtis | RXII | Stock option (right to buy) | D | 0,63 | 2.000 | 2.000 | |||||
| 2017-02-03 | 2017-02-01 | 4 | Kontulis Caitlin | RXII | Stock option (right to buy) | D | 0,63 | 2.500 | 2.500 | |||||
| 2017-02-03 | 2017-02-01 | 4 | Dorman H. Paul | RXII | Stock option (right to buy) | D | 0,63 | 2.000 | 2.000 | |||||
| 2017-01-26 | 2017-01-25 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6968 | 9.700 | 7 | 72.583 | ||||
| 2017-01-26 | 2017-01-25 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6900 | 300 | 0 | 62.883 | ||||
| 2017-01-19 | 2017-01-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6949 | 600 | 0 | 62.583 | ||||
| 2017-01-19 | 2017-01-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6946 | 3.000 | 2 | 61.983 | ||||
| 2017-01-19 | 2017-01-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6950 | 6.400 | 4 | 58.983 | ||||
| 2017-01-17 | 3 | Eliseev Alexey | RXII | Common stock, $0.0001 par value | D | 1.635.626 | ||||||||
| 2017-01-17 | 3 | Eliseev Alexey | RXII | Common stock, $0.0001 par value | D | 1.635.626 | ||||||||
| 2017-01-03 | 2016-12-30 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,7260 | 2.000 | 1 | 52.583 | ||||
| 2016-12-27 | 2016-12-23 | 4 | CAUWENBERGH GEERT By spouse | RXII | Common stock, $0.0001 par value | I | 0,7190 | 3.000 | 2 | 4.500 | ||||
| 2016-12-23 | 2016-12-22 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,7490 | 3.000 | 2 | 53.583 | ||||
| 2016-12-20 | 2016-12-16 | 4 | Pavco Pamela | RXII | Common stock warrant | D | 0,90 | 11.111 | 11.111 | |||||
| 2016-12-20 | 2016-12-16 | 4 | Pavco Pamela | RXII | Common stock, $0.0001 par value | D | 0,9000 | 11.111 | 10 | 17.173 | ||||
| 2016-12-20 | 2016-12-16 | 4 | CAUWENBERGH GEERT | RXII | Common stock warrant | D | 0,90 | 33.333 | 33.333 | |||||
| 2016-12-20 | 2016-12-16 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,9000 | 33.333 | 30 | 50.583 | ||||
| 2016-02-12 | 2016-02-10 | 4 | Pavco Pamela | RXII | Stock option (right to buy) | D | 0,29 | 66.000 | 66.000 | |||||
| 2016-02-12 | 2016-02-10 | 4 | CAUWENBERGH GEERT | RXII | Stock option (right to buy) | D | 0,29 | 133.000 | 133.000 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Bitterman Robert J | RXII | Stock option (right to buy) | D | 0,29 | 16.666 | 16.666 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Brownlie Keith L | RXII | Stock option (right to buy) | D | 0,29 | 16.666 | 16.666 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Lockshin Curtis | RXII | Stock option (right to buy) | D | 0,29 | 16.666 | 16.666 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Kontulis Caitlin | RXII | Stock option (right to buy) | D | 0,29 | 20.000 | 20.000 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Dorman H. Paul | RXII | Stock option (right to buy) | D | 0,29 | 16.666 | 16.666 | |||||
| 2015-06-23 | 2015-06-22 | 4 | CAUWENBERGH GEERT | RXII | Overallotment purchase right | D | 0,46 | -35.000 | 0 | |||||
| 2015-06-23 | 2015-06-22 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,4550 | 35.000 | 16 | 172.500 | ||||
| 2015-06-03 | 2015-06-02 | 4 | Bitterman Robert J | RXII | Overallotment purchase rights | D | 0,46 | 18.750 | 18.750 | |||||
| 2015-06-03 | 2015-06-02 | 4 | Bitterman Robert J | RXII | Common stock warrants | D | 0,52 | 18.750 | 18.750 | |||||
| 2015-06-03 | 2015-06-02 | 4 | Bitterman Robert J | RXII | Common stock, $0.0001 par value | D | 0,4000 | 37.500 | 15 | 44.000 | ||||
| 2015-06-03 | 2015-06-02 | 4 | CAUWENBERGH GEERT By spouse | RXII | Overallotment purchase right | I | 0,46 | 5.000 | 5.000 | |||||
| 2015-06-03 | 2015-06-02 | 4 | CAUWENBERGH GEERT By spouse | RXII | Common stock warrant | I | 0,52 | 5.000 | 5.000 | |||||
| 2015-06-03 | 2015-06-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock warrant | D | 0,52 | 35.000 | 35.000 | |||||
| 2015-06-03 | 2015-06-02 | 4 | CAUWENBERGH GEERT | RXII | Overallotment purchase right | D | 0,46 | 35.000 | 35.000 | |||||
| 2015-06-03 | 2015-06-02 | 4 | CAUWENBERGH GEERT By spouse | RXII | Common stock, $0.0001 par value | I | 0,4000 | 10.000 | 4 | 15.000 | ||||
| 2015-06-03 | 2015-06-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,4000 | 70.000 | 28 | 137.500 | ||||
| 2015-06-03 | 2015-06-02 | 4 | Lockshin Curtis | RXII | Overallotment purchase right | D | 0,46 | 6.000 | 6.000 | |||||
| 2015-06-03 | 2015-06-02 | 4 | Lockshin Curtis | RXII | Common stock warrant | D | 0,52 | 6.000 | 6.000 | |||||
| 2015-06-03 | 2015-06-02 | 4 | Lockshin Curtis | RXII | Common stock, $0.0001 par value | D | 0,4000 | 12.000 | 5 | 13.000 | ||||
| 2015-06-03 | 2015-06-02 | 4 | Pavco Pamela | RXII | Common stock purchase warrant | D | 0,52 | 6.250 | 6.250 | |||||
| 2015-06-03 | 2015-06-02 | 4 | Pavco Pamela | RXII | Overallotment purchase right | D | 0,46 | 6.250 | 6.250 | |||||
| 2015-06-03 | 2015-06-02 | 4 | Pavco Pamela | RXII | Common stock, $0.0001 par value | D | 0,4000 | 12.500 | 5 | 33.718 | ||||
| 2015-06-03 | 2015-06-02 | 4 | Dorman H. Paul | RXII | Overallotment purchase right | D | 0,46 | 18.750 | 18.750 | |||||
| 2015-06-03 | 2015-06-02 | 4 | Dorman H. Paul | RXII | Common stock warrant | D | 0,52 | 18.750 | 18.750 | |||||
| 2015-06-03 | 2015-06-02 | 4 | Dorman H. Paul | RXII | Common stock, $0.0001 par value | D | 0,4000 | 37.500 | 15 | 37.500 | ||||
| 2015-06-02 | 2015-06-01 | 4 | Pavco Pamela | RXII | Stock option (right to buy) | D | 0,38 | 66.000 | 66.000 | |||||
| 2015-06-02 | 2015-06-01 | 4 | CAUWENBERGH GEERT | RXII | Stock option (right to buy) | D | 0,38 | 133.000 | 133.000 | |||||
| 2015-06-02 | 2015-06-01 | 4 | Bitterman Robert J | RXII | Stock option (right to buy) | D | 0,38 | 16.666 | 16.666 | |||||
| 2015-06-02 | 2015-06-01 | 4 | Brownlie Keith L | RXII | Stock option (right to buy) | D | 0,38 | 16.666 | 16.666 | |||||
| 2015-06-02 | 2015-06-01 | 4 | Lockshin Curtis | RXII | Stock option (right to buy) | D | 0,38 | 16.666 | 16.666 | |||||
| 2015-06-02 | 2015-06-01 | 4 | Kontulis Caitlin | RXII | Stock option (right to buy) | D | 0,38 | 10.000 | 10.000 | |||||
| 2015-06-02 | 2015-06-01 | 4 | Dorman H. Paul | RXII | Stock option (right to buy) | D | 0,38 | 16.666 | 16.666 | |||||
| 2015-04-02 | 2015-04-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,7192 | 5.000 | 4 | 67.500 | ||||
| 2015-02-18 | 2015-02-17 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 1,1700 | 4.000 | 5 | 62.500 | ||||
| 2015-02-11 | 2015-02-10 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 1,2499 | 1.156 | 1 | 58.500 | ||||
| 2015-02-11 | 2015-02-10 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 1,2400 | 644 | 1 | 57.344 | ||||
| 2015-02-11 | 2015-02-10 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 1,2200 | 200 | 0 | 56.700 | ||||
| 2015-01-23 | 2015-01-22 | 4 | Bitterman Robert J | RXII | Common stock, $0.0001 par value | D | 1,1900 | 1.853 | 2 | 6.500 | ||||
| 2015-01-23 | 2015-01-22 | 4 | Bitterman Robert J | RXII | Common stock, $0.0001 par value | D | 1,2000 | 3.147 | 4 | 4.647 | ||||
| 2015-01-20 | 2015-01-20 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 1,0300 | 10.000 | 10 | 56.500 | ||||
| 2014-12-31 | 2014-12-30 | 4 | CAUWENBERGH GEERT | RXII | Common Stock, $0.0001 par value | D | 1,5893 | 500 | 1 | 46.500 | ||||
| 2014-12-31 | 2014-12-30 | 4 | CAUWENBERGH GEERT | RXII | Common Stock, $0.0001 par value | D | 1,5867 | 2.000 | 3 | 46.000 | ||||
| 2014-10-14 | 2014-10-13 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 1,6799 | 3.000 | 5 | 44.000 | ||||
| 2014-09-23 | 2014-09-19 | 4 | CAUWENBERGH GEERT By child | RXII | Common stock, $0.0001 | I | 2,2000 | 4.500 | 10 | 4.500 | ||||
| 2014-09-16 | 2014-09-16 | 4 | CAUWENBERGH GEERT By Spouse | RXII | Common stock, $0.0001 par value | I | 2,0780 | 5.000 | 10 | 46.000 | ||||
| 2014-09-15 | 2014-09-15 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,1900 | 2.000 | 4 | 41.000 | ||||
| 2014-09-15 | 2014-09-15 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,1899 | 3.000 | 7 | 39.000 | ||||
| 2014-09-15 | 2014-09-15 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,1799 | 5.000 | 11 | 36.000 | ||||
| 2014-08-04 | 2014-07-31 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 2,4800 | 400 | 1 | 1.221.723 | ||||
| 2014-07-17 | 2014-07-15 | 4 | CAUWENBERGH GEERT | RXII | Common Stock, $0.0001 par value | D | 2,5000 | 1.000 | 2 | 31.000 | ||||
| 2014-07-09 | 2014-07-09 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,5699 | 1.400 | 4 | 30.000 | ||||
| 2014-07-02 | 2014-07-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,8600 | 300 | 1 | 28.600 | ||||
| 2014-07-02 | 2014-07-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,8599 | 1.000 | 3 | 28.300 | ||||
| 2014-07-02 | 2014-07-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,8500 | 700 | 2 | 27.300 | ||||
| 2014-06-26 | 2014-06-25 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,0100 | 500 | 2 | 26.600 | ||||
| 2014-06-19 | 2014-06-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,9600 | 800 | 2 | 26.100 | ||||
| 2014-06-19 | 2014-06-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,0000 | 200 | 1 | 25.300 | ||||
| 2014-06-19 | 2014-06-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,9921 | 1.000 | 3 | 25.100 | ||||
| 2014-06-09 | 2014-06-09 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,0499 | 800 | 2 | 24.100 | ||||
| 2014-06-09 | 2014-06-09 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,0500 | 200 | 1 | 23.300 | ||||
| 2014-06-05 | 2014-06-04 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,9715 | 1.000 | 3 | 23.100 | ||||
| 2014-06-05 | 2014-06-04 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,9140 | 1.000 | 3 | 22.100 | ||||
| 2014-06-04 | 2014-06-02 | 4 | Bitterman Robert J | RXII | Stock Option (right to buy) | D | 2,85 | 16.666 | 16.666 | |||||
| 2014-06-04 | 2014-06-02 | 4 | Brownlie Keith L | RXII | Stock Option (right to buy) | D | 2,85 | 16.666 | 16.666 | |||||
| 2014-06-04 | 2014-06-02 | 4 | Lockshin Curtis | RXII | Stock Option (right to buy) | D | 2,85 | 16.666 | 16.666 | |||||
| 2014-06-04 | 2014-06-02 | 4 | CAUWENBERGH GEERT | RXII | Stock Option (right to buy) | D | 2,85 | 133.000 | 133.000 | |||||
| 2014-06-04 | 2014-06-02 | 4 | Pavco Pamela | RXII | Stock Option (right to buy) | D | 2,85 | 66.000 | 66.000 | |||||
| 2014-06-04 | 2014-06-02 | 4 | Kontulis Caitlin | RXII | Stock Option (right to buy) | D | 2,85 | 10.000 | 10.000 | |||||
| 2014-06-04 | 2014-06-02 | 4 | Dorman H. Paul | RXII | Stock Option (right to buy) | D | 2,85 | 16.666 | 16.666 | |||||
| 2014-05-15 | 2014-04-22 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 4,1100 | -5.000 | -21 | 1.250.315 | ||||
| 2014-03-26 | 2014-03-20 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,0000 | -2.000 | -12 | 1.255.315 | ||||
| 2014-03-26 | 2014-03-12 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 5,5500 | -1.941 | -11 | 1.257.315 | ||||
| 2014-03-26 | 2014-03-12 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 5,7000 | -1.000 | -6 | 1.259.256 | ||||
| 2014-03-26 | 2014-03-12 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 5,6100 | -1.000 | -6 | 1.260.256 | ||||
| 2014-03-26 | 2014-03-12 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 5,5500 | -59 | -0 | 1.261.256 | ||||
| 2014-03-26 | 2014-03-06 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,1000 | -1.400 | -9 | 1.261.315 | ||||
| 2014-03-26 | 2014-03-06 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,1000 | -500 | -3 | 1.262.715 | ||||
| 2014-03-26 | 2014-03-06 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,1100 | -100 | -1 | 1.263.215 | ||||
| 2014-03-26 | 2014-03-05 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,0000 | -2.000 | -12 | 1.263.315 | ||||
| 2014-03-21 | 2014-02-28 | 4/A | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,2000 | -2.600 | -16 | 1.247.315 | ||||
| 2014-03-21 | 2014-02-27 | 4/A | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,1000 | -400 | -2 | 1.276.915 | ||||
| 2014-03-11 | 2014-03-04 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 5,8000 | -2.000 | -12 | 1.265.315 | ||||
| 2014-03-11 | 2014-03-04 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 5,9100 | -2.000 | -12 | 1.267.315 | ||||
| 2014-03-11 | 2014-03-03 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,1500 | -5.000 | -31 | 1.269.315 | ||||
| 2014-03-11 | 2014-02-28 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,2000 | 2.600 | 16 | 1.274.315 | ||||
| 2014-03-11 | 2014-02-27 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,1000 | 400 | 2 | 1.276.915 | ||||
| 2014-03-11 | 2014-02-27 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,1100 | -1.300 | -8 | 1.277.315 | ||||
| 2014-03-11 | 2014-02-27 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,4500 | -5.000 | -32 | 1.278.615 | ||||
| 2014-03-11 | 2014-02-26 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,0300 | -400 | -2 | 1.283.615 | ||||
| 2014-03-11 | 2014-02-25 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,5500 | -5.000 | -33 | 1.284.015 | ||||
| 2014-03-11 | 2014-02-25 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,0000 | -5.000 | -30 | 1.289.015 | ||||
| 2014-03-06 | 2014-02-24 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,3000 | -1.575 | -10 | 1.266.585 | ||||
| 2014-03-06 | 2014-02-21 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 5,0000 | -5.000 | -25 | 1.268.160 | ||||
| 2014-03-06 | 2014-02-21 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 4,8500 | -5.000 | -24 | 1.273.160 | ||||
| 2014-03-06 | 2014-02-21 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 5,1500 | -5.000 | -26 | 1.278.160 | ||||
| 2014-03-06 | 2014-02-21 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 4,8000 | -576 | -3 | 1.283.160 | ||||
| 2014-03-06 | 2014-02-21 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 4,7100 | -2.100 | -10 | 1.283.736 | ||||
| 2014-03-06 | 2014-02-21 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 4,7350 | -2.900 | -14 | 1.285.836 | ||||
| 2014-03-06 | 2014-02-21 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 4,7500 | -5.641 | -27 | 1.288.736 | ||||
| 2014-03-06 | 2014-02-20 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 4,7000 | -1.200 | -6 | 1.294.377 | ||||
| 2013-11-01 | 2013-10-31 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,1900 | 800 | 3 | 21.100 | ||||
| 2013-11-01 | 2013-10-30 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,0900 | 200 | 1 | 20.300 | ||||
| 2013-10-24 | 2013-10-23 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,3400 | 1.000 | 3 | 20.100 | ||||
| 2013-10-22 | 2013-10-22 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,4300 | 300 | 1 | 19.100 | ||||
| 2013-10-22 | 2013-10-18 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5000 | 200 | 1 | 18.800 | ||||
| 2013-10-22 | 2013-10-18 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,3800 | 100 | 0 | 18.600 | ||||
| 2013-10-22 | 2013-10-18 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,2900 | 100 | 0 | 18.500 | ||||
| 2013-10-16 | 2013-10-16 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5300 | 100 | 0 | 18.400 | ||||
| 2013-10-16 | 2013-10-15 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5100 | 100 | 0 | 18.300 | ||||
| 2013-10-16 | 2013-10-14 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5400 | 100 | 0 | 18.200 | ||||
| 2013-10-09 | 2013-10-09 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,1500 | 1.000 | 3 | 18.100 | ||||
| 2013-10-07 | 2013-10-04 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,4900 | 200 | 1 | 17.100 | ||||
| 2013-10-07 | 2013-10-03 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5100 | 100 | 0 | 16.900 | ||||
| 2013-10-02 | 2013-09-30 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,4200 | 300 | 1 | 16.800 | ||||
| 2013-09-26 | 2013-09-26 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5000 | 300 | 1 | 16.500 | ||||
| 2013-09-26 | 2013-09-24 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,4900 | 100 | 0 | 16.200 | ||||
| 2013-09-24 | 2013-09-23 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,4900 | 174 | 1 | 16.100 | ||||
| 2013-09-23 | 2013-09-20 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5200 | 326 | 1 | 15.926 | ||||
| 2013-09-19 | 2013-09-18 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,4800 | 100 | 0 | 15.600 | ||||
| 2013-09-19 | 2013-09-18 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5000 | 100 | 0 | 15.500 | ||||
| 2013-09-17 | 2013-09-17 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5500 | 200 | 1 | 15.400 | ||||
| 2013-09-16 | 2013-09-13 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,6000 | 100 | 0 | 15.200 | ||||
| 2013-09-16 | 2013-09-13 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5500 | 100 | 0 | 15.100 | ||||
| 2013-09-12 | 2013-09-11 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5500 | 150 | 1 | 15.000 | ||||
| 2013-09-12 | 2013-09-10 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5800 | 150 | 1 | 14.850 | ||||
| 2013-09-12 | 2013-09-10 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,6500 | 200 | 1 | 14.700 | ||||
| 2013-09-03 | 2013-08-30 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,3500 | 200 | 1 | 14.500 | ||||
| 2013-09-03 | 2013-08-30 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,3800 | 100 | 0 | 14.300 | ||||
| 2013-08-30 | 2013-08-29 | 4 | Lockshin Curtis | RXII | Common stock, $0.0001 par value | D | 3,7000 | 1.000 | 4 | 1.000 | ||||
| 2013-08-30 | 2013-08-29 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5500 | 200 | 1 | 14.200 | ||||
| 2013-08-30 | 2013-08-29 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,4000 | 200 | 1 | 14.000 | ||||
| 2013-08-29 | 2013-08-28 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,7000 | 100 | 0 | 13.800 | ||||
| 2013-08-29 | 2013-08-28 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,6000 | 100 | 0 | 13.700 | ||||
| 2013-08-29 | 2013-08-28 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,7500 | 200 | 1 | 13.600 | ||||
| 2013-08-28 | 2013-08-27 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,7000 | 100 | 0 | 13.400 | ||||
| 2013-08-27 | 2013-08-26 | 4 | Bitterman Robert J | RXII | Common stock, $0.0001 par value | D | 3,9000 | 500 | 2 | 1.500 | ||||
| 2013-08-26 | 2013-08-23 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,6900 | 200 | 1 | 13.300 | ||||
| 2013-08-26 | 2013-08-23 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,7500 | 100 | 0 | 13.100 | ||||
| 2013-08-23 | 2013-08-22 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,6200 | 300 | 1 | 13.000 | ||||
| 2013-08-22 | 2013-08-21 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,8000 | 680 | 3 | 12.700 | ||||
| 2013-08-21 | 2013-08-20 | 4 | CAUWENBERGH GEERT | RXII | Common Stock, $0.0001 par value | D | 3,7500 | 200 | 1 | 12.020 | ||||
| 2013-08-21 | 2013-08-20 | 4 | CAUWENBERGH GEERT | RXII | Common Stock, $0.0001 par value | D | 3,7000 | 200 | 1 | 11.820 | ||||
| 2013-08-21 | 2013-08-20 | 4 | CAUWENBERGH GEERT | RXII | Common Stock, $0.0001 par value | D | 3,9000 | 300 | 1 | 11.620 | ||||
| 2013-08-20 | 2013-08-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,6500 | 100 | 0 | 11.320 | ||||
| 2013-08-20 | 2013-08-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,6700 | 120 | 0 | 11.220 | ||||
| 2013-08-20 | 2013-08-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,8600 | 100 | 0 | 11.100 | ||||
| 2013-08-06 | 2013-08-06 | 4 | CAUWENBERGH GEERT | RXII | Common stock, par value $0.0001 | D | 4,0500 | 350 | 1 | 11.000 | ||||
| 2013-08-06 | 2013-08-05 | 4 | CAUWENBERGH GEERT | RXII | Common stock, par value $0.0001 | D | 4,0300 | 150 | 1 | 10.650 | ||||
| 2013-08-06 | 2013-08-05 | 4 | CAUWENBERGH GEERT | RXII | Common stock, par value $0.0001 | D | 4,0000 | 500 | 2 | 10.500 | ||||
| 2013-08-05 | 2013-08-05 | 4 | Bitterman Robert J | RXII | Common stock, par value $0.0001 | D | 4,0500 | 100 | 0 | 1.000 | ||||
| 2013-08-05 | 2013-08-05 | 4 | Bitterman Robert J | RXII | Common stock, par value $0.0001 | D | 4,0200 | 100 | 0 | 900 | ||||
| 2013-08-05 | 2013-08-05 | 4 | Bitterman Robert J | RXII | Common stock, par value $0.0001 | D | 4,0100 | 100 | 0 | 800 | ||||
| 2013-08-05 | 2013-08-05 | 4 | Bitterman Robert J | RXII | Common stock, par value $0.0001 | D | 4,0500 | 200 | 1 | 700 | ||||
| 2013-08-05 | 2013-08-05 | 4 | Bitterman Robert J | RXII | Common stock, par value $0.0001 | D | 4,1300 | 500 | 2 | 500 | ||||
| 2013-07-31 | 2013-07-31 | 4 | CAUWENBERGH GEERT | RXII | Common stock, par value $0.0001 | D | 4,1000 | 500 | 2 | 9.833 | ||||
| 2013-07-31 | 2013-07-31 | 4 | CAUWENBERGH GEERT | RXII | Common stock, par value $0.0001 | D | 4,0200 | 167 | 1 | 10.000 | ||||
| 2013-07-31 | 2013-07-23 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1580 | -28.000 | -4 | 38.820.446 | ||||
| 2013-07-30 | 2013-07-29 | 4 | CAUWENBERGH GEERT | RXII | Common stock, par value $0.0001 | D | 4,5400 | 500 | 2 | 9.333 | ||||
| 2013-07-29 | 2013-07-26 | 4 | CAUWENBERGH GEERT | RXII | Common stock, par value $0.0001 | D | 4,8700 | 500 | 2 | 8.833 | ||||
| 2013-07-22 | 2013-07-19 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1490 | -111.684 | -17 | 38.918.656 | ||||
| 2013-07-22 | 2013-07-18 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1535 | -100.000 | -15 | 38.960.130 | ||||
| 2013-07-22 | 2013-07-18 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1525 | -100.000 | -15 | 39.060.130 | ||||
| 2013-07-22 | 2013-07-17 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1600 | -100.000 | -16 | 39.160.130 | ||||
| 2013-07-15 | 2013-07-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1980 | -95.000 | -19 | 39.260.130 | ||||
| 2013-07-15 | 2013-07-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1990 | -5.000 | -1 | 39.355.130 | ||||
| 2013-07-15 | 2013-07-10 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1950 | -100.000 | -20 | 39.360.130 | ||||
| 2013-07-15 | 2013-07-10 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1950 | -100.000 | -20 | 39.360.130 | ||||
| 2013-07-15 | 2013-07-10 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1960 | -30.000 | -6 | 39.560.130 | ||||
| 2013-07-08 | 2013-07-05 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1950 | -18.180 | -4 | 39.590.130 | ||||
| 2013-07-08 | 2013-07-05 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1940 | -100.000 | -19 | 39.608.310 | ||||
| 2013-07-08 | 2013-07-03 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1945 | -50.000 | -10 | 39.708.310 | ||||
| 2013-07-08 | 2013-07-03 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1930 | -50.000 | -10 | 39.758.310 | ||||
| 2013-07-03 | 2013-07-02 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1930 | -30.000 | -6 | 39.808.310 | ||||
| 2013-07-03 | 2013-07-02 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1970 | -9.249 | -2 | 39.838.310 | ||||
| 2013-07-03 | 2013-07-01 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1970 | -50.000 | -10 | 39.847.559 | ||||
| 2013-07-03 | 2013-07-01 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1965 | -50.000 | -10 | 39.897.559 | ||||
| 2013-07-02 | 2013-06-28 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1980 | -46.874 | -9 | 39.947.559 | ||||
| 2013-07-02 | 2013-06-27 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1930 | -45.000 | -9 | 39.994.433 | ||||
| 2013-07-02 | 2013-06-27 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1930 | -60.000 | -12 | 40.039.433 | ||||
| 2013-07-02 | 2013-06-27 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1980 | -50.000 | -10 | 40.099.433 | ||||
| 2013-07-02 | 2013-06-26 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1980 | -25.500 | -5 | 40.149.433 | ||||
| 2013-07-02 | 2013-06-26 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1950 | -50.000 | -10 | 40.174.933 | ||||
| 2013-07-02 | 2013-06-25 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1940 | -50.000 | -10 | 40.224.933 | ||||
| 2013-06-11 | 2013-06-07 | 4 | CAUWENBERGH GEERT | RXII | Stock Option (right to buy) | D | 0,20 | 4.000.000 | 4.000.000 | |||||
| 2013-06-11 | 2013-06-07 | 4 | Pavco Pamela | RXII | Stock Option (right to buy) | D | 0,20 | 2.000.000 | 2.000.000 | |||||
| 2013-06-11 | 2013-06-07 | 4 | Bitterman Robert J | RXII | Stock Option (right to buy) | D | 0,20 | 500.000 | 500.000 | |||||
| 2013-06-11 | 2013-06-07 | 4 | Brownlie Keith L | RXII | Stock Option (right to buy) | D | 0,20 | 500.000 | 500.000 | |||||
| 2013-06-11 | 2013-06-07 | 4 | Kontulis Caitlin | RXII | Stock Option (right to buy) | D | 0,20 | 300.000 | 300.000 | |||||
| 2013-05-03 | 2013-04-18 | 4/A | Lockshin Curtis | RXII | Stock Option (right to buy) | D | 0,24 | 1.000.000 | 1.000.000 | |||||
| 2013-05-03 | 2013-04-18 | 4/A | Dorman H. Paul | RXII | Stock Option (right to buy) | D | 0,24 | 1.000.000 | 1.000.000 | |||||
| 2013-05-02 | 2013-05-02 | 4 | Galena Biopharma, Inc. | RXII | Common Stock, $0.0001 par value | D | 0,1905 | -253.000 | -48 | 32.393.095 | ||||
| 2013-05-02 | 2013-05-01 | 4 | Galena Biopharma, Inc. | RXII | Common Stock, $0.0001 par value | D | 0,1925 | -659.500 | -127 | 32.646.095 | ||||
| 2013-05-02 | 2013-04-30 | 4 | Galena Biopharma, Inc. | RXII | Common Stock, $0.0001 par value | D | 0,2138 | -171.000 | -37 | 33.305.595 | ||||
| 2013-04-23 | 2013-03-18 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,3480 | -52.900 | -18 | 39.831.365 | ||||
| 2013-04-23 | 2013-03-15 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,3250 | -100.000 | -32 | 39.884.265 | ||||
| 2013-04-23 | 2013-03-14 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,3310 | -126.843 | -42 | 39.984.265 | ||||
| 2013-04-23 | 2013-03-14 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,3340 | -7.500 | -3 | 40.111.108 | ||||
| 2013-04-23 | 2013-03-12 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,2720 | -100.000 | -27 | 40.118.608 | ||||
| 2013-04-23 | 2013-03-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,2730 | -100.000 | -27 | 40.218.608 | ||||
| 2013-04-23 | 2013-03-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,2210 | -100.000 | -22 | 40.318.608 | ||||
| 2013-04-23 | 2013-03-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,2400 | -100.000 | -24 | 40.418.608 | ||||
| 2013-04-23 | 2013-03-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,2330 | -100.000 | -23 | 40.518.608 | ||||
| 2013-04-23 | 2013-03-08 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1940 | -50.000 | -10 | 40.618.608 | ||||
| 2013-04-23 | 2013-03-07 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1950 | -50.000 | -10 | 40.668.608 | ||||
| 2013-04-23 | 2013-03-06 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1490 | -36.570 | -5 | 40.718.608 | ||||
| 2013-04-23 | 2013-03-05 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1450 | -30.000 | -4 | 40.755.178 | ||||
| 2013-04-23 | 2013-03-04 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 | D | 0,1450 | -50.000 | -7 | 40.785.178 | ||||
| 2013-04-23 | 2013-03-01 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 | D | 0,1500 | -20.000 | -3 | 40.835.178 | ||||
| 2013-04-23 | 2013-02-28 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1600 | -200 | -0 | 40.855.178 | ||||
| 2013-04-23 | 2013-02-27 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1600 | -29.888 | -5 | 40.855.378 | ||||
| 2013-04-23 | 2013-02-26 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1750 | -4.000 | -1 | 40.885.266 | ||||
| 2013-04-23 | 2013-02-25 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1820 | -8.000 | -1 | 40.889.266 | ||||
| 2013-04-23 | 2013-02-25 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1800 | -92.000 | -17 | 40.897.266 | ||||
| 2013-04-23 | 2013-02-22 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1600 | -40.000 | -6 | 40.989.266 | ||||
| 2013-04-23 | 2013-02-19 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1920 | -1.000 | -0 | 41.029.266 | ||||
| 2013-04-23 | 2013-02-19 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1900 | -49.000 | -9 | 41.030.266 | ||||
| 2013-04-23 | 2013-02-15 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1360 | -40.000 | -5 | 41.079.266 | ||||
| 2013-04-23 | 2013-02-14 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1160 | -30.000 | -3 | 41.119.266 | ||||
| 2013-04-23 | 2013-02-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,0910 | -20.000 | -2 | 41.149.266 | ||||
| 2013-04-23 | 2013-02-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,0950 | -20.000 | -2 | 41.169.266 | ||||
| 2013-04-23 | 2013-02-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1150 | -40.000 | -5 | 41.189.266 | ||||
| 2013-04-23 | 2013-02-06 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,0860 | -20.000 | -2 | 41.229.266 | ||||
| 2013-04-23 | 2013-02-05 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,0760 | -10.000 | -1 | 41.249.266 | ||||
| 2013-04-23 | 2013-03-21 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,2320 | -48.500 | -11 | 39.684.265 | ||||
| 2013-04-23 | 2013-03-20 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,2310 | -57.100 | -13 | 39.732.765 | ||||
| 2013-04-23 | 2013-03-20 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,2550 | -1.500 | -0 | 39.789.865 | ||||
| 2013-04-23 | 2013-03-19 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,3000 | -40.000 | -12 | 39.791.365 | ||||
| 2013-04-22 | 2013-04-18 | 4 | Lockshin Curtis | RXII | Stock Option (right to buy) | D | 0,24 | 1.000.000 | 1.000.000 | |||||
| 2013-04-22 | 2013-04-18 | 4 | Dorman H. Paul | RXII | Stock Option (right to buy) | D | 0,24 | 1.000.000 | 1.000.000 | |||||
| 2013-03-19 | 3 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 41.259.266 | ||||||||
| 2013-03-13 | 3 | Opko Health, Inc. | RXII | Common Stock | D | 67.241.380 | ||||||||
| 2013-03-08 | 2013-03-06 | 4 | CAUWENBERGH GEERT | RXII | Common Stock | D | 0,1450 | 250.000 | 36 | 250.000 | ||||
| 2013-03-01 | 3 | Pavco Pamela | RXII | Common stock, par value $0.0001 | D | 90.153 | ||||||||
| 2013-03-01 | 3 | Galena Biopharma, Inc. | RXII | Common stock, $0.0001 par value | D | 33.476.595 | ||||||||
| 2013-03-01 | 3 | Kontulis Caitlin | RXII | Common stock, par value $0.0001 | D | 2.231 |
P
Türev olmayan veya türev menkul kıymetlerin açık piyasa veya özel alımı
S
Türev olmayan veya türev menkul kıymetlerin açık piyasa veya özel satımı
A
Şirketten menkul kıymetlerin verilmesi, ödüllendirilmesi veya başka şekilde edinilmesi (opsiyon gibi)
C
Türevin dönüşümü
D
Menkul kıymetlerin şirkete geri satışı veya devri
F
Kullanım bedelinin veya vergi yükümlülüğünün şirketten alınan menkul kıymetlerin bir kısmı kullanılarak ödenmesi
G
Menkul kıymetlerin içeriden birine veya kişiye hediye edilmesi
K
Özkaynak swapları ve benzeri riskten korunma işlemleri
M
Şirketten alınan türev menkul kıymetin kullanılması veya dönüştürülmesi (opsiyon gibi)
V
Form 4te gönüllü olarak bildirilen bir işlem
J
Diğer (işlemi açıklayan bir dipnotla birlikte)
